Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 18, 2023 - Issue
Submit an article Journal homepage
109
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants

Weimin Li1 Clinical Trial Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6685-0161View further author information
ORCID Icon,
Sami Z Daoud2 Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
View further author information
,
Roopa Trivedi3 Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USAView further author information
,
Pradeep B Lukka4 Clinical & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Eulalia Jimenez5 Clinical & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Barcelona, SpainView further author information
,
Eduard Molins5 Clinical & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Barcelona, SpainView further author information
,
Catherine Stewart6 Statistics, Phastar, Chiswick, London, UKView further author information
,
Pranob Bharali3 Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA;7 BioPharmaceuticals R&D Late-Stage Development, AstraZeneca India Pvt Ltd., Bangalore, Karnataka, IndiaView further author information
&
Esther Garcia-Gil8 Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, SpainView further author information
 show all
Pages 2725-2735 | Received 07 Sep 2023, Accepted 07 Nov 2023, Published online: 26 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.